
NEOVASC INC (NVCN) Fundamental Analysis & Valuation
NASDAQ:NVCN • CA64065J4037
Current stock price
30.03 USD
+0.49 (+1.66%)
At close:
29.425 USD
-0.61 (-2.01%)
Pre-Market:
This NVCN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NVCN Profitability Analysis
1.1 Basic Checks
- NVCN had negative earnings in the past year.
- In the past year NVCN has reported a negative cash flow from operations.
1.2 Ratios
- NVCN has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- NVCN has a Gross Margin of 79.66%. This is amongst the best in the industry. NVCN outperforms 90.57% of its industry peers.
- NVCN's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for NVCN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.66% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y17.59%
2. NVCN Health Analysis
2.1 Basic Checks
- NVCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- NVCN has more shares outstanding than it did 1 year ago.
- Compared to 1 year ago, NVCN has a worse debt to assets ratio.
2.2 Solvency
- NVCN has an Altman-Z score of -16.71. This is a bad value and indicates that NVCN is not financially healthy and even has some risk of bankruptcy.
- NVCN has a worse Altman-Z score (-16.71) than 87.26% of its industry peers.
- A Debt/Equity ratio of 0.81 indicates that NVCN is somewhat dependend on debt financing.
- NVCN's Debt to Equity ratio of 0.81 is on the low side compared to the rest of the industry. NVCN is outperformed by 75.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.71 |
ROIC/WACCN/A
WACC9.15%
2.3 Liquidity
- A Current Ratio of 2.96 indicates that NVCN has no problem at all paying its short term obligations.
- NVCN has a Current ratio (2.96) which is in line with its industry peers.
- A Quick Ratio of 2.85 indicates that NVCN has no problem at all paying its short term obligations.
- NVCN's Quick ratio of 2.85 is in line compared to the rest of the industry. NVCN outperforms 52.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.85 |
3. NVCN Growth Analysis
3.1 Past
- The earnings per share for NVCN have decreased strongly by -1143.35% in the last year.
- Looking at the last year, NVCN shows a very strong growth in Revenue. The Revenue has grown by 49.47%.
- The Revenue has been decreasing by -6.73% on average over the past years.
EPS 1Y (TTM)-1143.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.5%
Revenue 1Y (TTM)49.47%
Revenue growth 3Y22.11%
Revenue growth 5Y-6.73%
Sales Q2Q%91.39%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. NVCN Valuation Analysis
4.1 Price/Earnings Ratio
- NVCN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. NVCN Dividend Analysis
5.1 Amount
- No dividends for NVCN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NVCN Fundamentals: All Metrics, Ratios and Statistics
30.03
+0.49 (+1.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-23 2023-03-23/amc
Earnings (Next)05-10 2023-05-10/amc
Inst Owners14.64%
Inst Owner Change-24.47%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap82.70M
Revenue(TTM)3.81M
Net Income(TTM)-41.20M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 21.73 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.22 | ||
| P/tB | 5.22 | ||
| EV/EBITDA | N/A |
EPS(TTM)-105.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-9.07
FCFYN/A
OCF(TTM)-9.05
OCFYN/A
SpS1.38
BVpS5.75
TBVpS5.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.66% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y17.59%
F-Score3
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 16.27% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.85 | ||
| Altman-Z | -16.71 |
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)28.29%
Cap/Depr(5y)34.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1143.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.47%
Revenue growth 3Y22.11%
Revenue growth 5Y-6.73%
Sales Q2Q%91.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.05%
OCF growth 3YN/A
OCF growth 5YN/A
NEOVASC INC / NVCN Fundamental Analysis FAQ
What is the fundamental rating for NVCN stock?
ChartMill assigns a fundamental rating of 2 / 10 to NVCN.
Can you provide the valuation status for NEOVASC INC?
ChartMill assigns a valuation rating of 1 / 10 to NEOVASC INC (NVCN). This can be considered as Overvalued.
How profitable is NEOVASC INC (NVCN) stock?
NEOVASC INC (NVCN) has a profitability rating of 1 / 10.
What is the financial health of NEOVASC INC (NVCN) stock?
The financial health rating of NEOVASC INC (NVCN) is 3 / 10.